Home › Funds › Knott David M Jr › CNTB
Knott David M Jr position in CNTB
CONNECT BIOPHARMA HLDGS LTD · Health Care
Knott David M Jr reported holding 419,866 shares of CNTB (CONNECT BIOPHARMA HLDGS LTD) in its Q3 2026 13F filing — a position valued at US$462K, representing 0.25% of its reported portfolio and ranking #44 among its reported holdings. Knott David M Jr has disclosed CNTB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Knott David M Jr's CNTB position evolved
Knott David M Jr first disclosed a stake in CNTB in Q4 2025 at 200,000 shares (US$564K). The position peaked in Q2 2026 at 444,862 shares, worth US$1.1M. Across 4 filings, Knott David M Jr increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 419,866 shares valued at US$462K — a reduction of -24,996 shares quarter over quarter.. Notable position changes include a 94% increase in Q1 2026 (shares fell 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 200.00K | $564.00K | New |
| Q1 2026 | 387.83K | $1.02M | Add |
| Q2 2026 | 444.86K | $1.06M | Add |
| Q3 2026 | 419.87K | $461.85K | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNTB and 13F data
CNTB (CONNECT BIOPHARMA HLDGS LTD) is a Health Care company. 65 other funds we track also report a position in CNTB — the largest reported positions include Ikarian Capital, LLC (US$10.8M), BML Capital Management, LLC (US$4.3M), Richmond Brothers, Inc. (US$1.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNTB
- Ikarian Capital, LLC 4.54M sh · $10.80M · Q2 2026
- BML Capital Management, LLC 3.86M sh · $4.25M · Q3 2026
- Richmond Brothers, Inc. 535.61K sh · $1.27M · Q2 2026
- Stonepine Capital Management, LLC 364.25K sh · $866.92K · Q2 2026
More on Knott David M Jr
FAQ
How long has Knott David M Jr held CNTB?
Knott David M Jr has disclosed CNTB holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Knott David M Jr's current position in CNTB?
As of Q3 2026, Knott David M Jr holds 419.87K shares of CNTB (CONNECT BIOPHARMA HLDGS LTD), valued at $461.85K, representing 0.25% of its reported portfolio and ranking #44.
Has Knott David M Jr been buying or selling CNTB?
In the latest 13F filing (Q3 2026), Knott David M Jr reduced its position in CNTB. The position peaked in Q2 2026 at 444.86K shares.
Which other funds hold CNTB?
Other major institutional holders of CNTB include Ikarian Capital, LLC, BML Capital Management, LLC, Richmond Brothers, Inc., among 65 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.